Literature DB >> 26628296

Serum microRNAs as potential noninvasive biomarkers for glioma.

Xin Yu1, Zheng Li2.   

Abstract

Gliomas are derived from astroglial precursors or astrocytes, accounting for 40 % central nervous system tumors. MicroRNAs (miRNAs) are a class of endogenous, small (19- to 23-nucleotides) non-coding RNAs involved in cancer progression. Recent studies show that circulating miRNAs are associated with the clinicopathological features and prognosis of gliomas. Serum miRNAs may serve as novel biomarkers for gliomas diagnosis. This review explores the possibilities of using serum miRNAs as prognostic, diagnostic markers, and therapeutic targets in gliomas.

Entities:  

Keywords:  Biomarkers; Circulating miRNAs; Gliomas; MicroRNA; Serum miRNAs

Mesh:

Substances:

Year:  2015        PMID: 26628296     DOI: 10.1007/s13277-015-4515-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

Review 1.  Epigenetics in human gliomas.

Authors:  Simone Kreth; Niklas Thon; Friedrich W Kreth
Journal:  Cancer Lett       Date:  2012-04-21       Impact factor: 8.679

2.  The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.

Authors:  M Fareh; L Turchi; V Virolle; D Debruyne; F Almairac; S de-la-Forest Divonne; P Paquis; O Preynat-Seauve; K-H Krause; H Chneiweiss; T Virolle
Journal:  Cell Death Differ       Date:  2011-07-01       Impact factor: 15.828

Review 3.  Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Authors:  Alessandro Allegra; Andrea Alonci; Salvatore Campo; Giuseppa Penna; Annamaria Petrungaro; Demetrio Gerace; Caterina Musolino
Journal:  Int J Oncol       Date:  2012-10-01       Impact factor: 5.650

4.  New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers.

Authors:  L Zavesky; E Jandakova; R Turyna; L Langmeierova; V Weinberger; L Minar; M Kohoutova
Journal:  Neoplasma       Date:  2015       Impact factor: 2.575

Review 5.  MicroRNA as potential modulators in chemoresistant high-grade gliomas.

Authors:  Sharon Yin Yee Low; Yoon Khei Ho; Heng-Phon Too; Celestial Therese Yap; Wai Hoe Ng
Journal:  J Clin Neurosci       Date:  2013-10-06       Impact factor: 1.961

6.  Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas.

Authors:  Tao Tao; Yingyi Wang; Hui Luo; Lei Yao; Lin Wang; Jiajia Wang; Wei Yan; Junxia Zhang; Huibo Wang; Yan Shi; Yu Yin; Tao Jiang; Chunsheng Kang; Ning Liu; Yongping You
Journal:  Eur J Cancer       Date:  2013-06-26       Impact factor: 9.162

7.  Oedema-based model for diffuse low-grade gliomas: application to clinical cases under radiotherapy.

Authors:  M Badoual; C Gerin; C Deroulers; B Grammaticos; J-F Llitjos; C Oppenheim; P Varlet; J Pallud
Journal:  Cell Prolif       Date:  2014-06-19       Impact factor: 6.831

8.  Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma.

Authors:  Hua Dong; Li Luo; Shengjun Hong; Hoicheong Siu; Yanghua Xiao; Li Jin; Rui Chen; Momiao Xiong
Journal:  BMC Syst Biol       Date:  2010-11-29

Review 9.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

10.  Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype.

Authors:  Sohila Zadran; Francoise Remacle; Raphael Levine
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

View more
  8 in total

1.  Aberrant expression of TNRC6a and miR-21 during myocardial infarction.

Authors:  Liang Li; Qiang Chen; Chao Feng; Yongping Jin; Shudong Xia
Journal:  3 Biotech       Date:  2019-06-25       Impact factor: 2.406

2.  Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway.

Authors:  Feng Yang; Wenwei Liu; Xiaojuan Yan; Hanyun Zhou; Hongshen Zhang; Jianfei Liu; Ming Yu; Xiaoshan Zhu; Kezhong Ma
Journal:  Med Sci Monit       Date:  2016-10-06

3.  A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.

Authors:  Tao Zhu; Wen Gao; Xi Chen; Ying Zhang; Meijuan Wu; Ping Zhang; Shihua Wang
Journal:  Int J Gynecol Cancer       Date:  2017-01       Impact factor: 3.437

4.  A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.

Authors:  Chenkai Ma; Hong P T Nguyen; Rodney B Luwor; Stanley S Stylli; Andrew Gogos; Lucia Paradiso; Andrew H Kaye; Andrew P Morokoff
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

5.  Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF.

Authors:  Qian Li; Yongqiu Li; Dongsen Zhang; Haifeng Gao; Xuan Gao
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

6.  Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma.

Authors:  Yanguo Peng; Wangchun Wu; Zhanfang Shang; Wei Li; Shuiyu Chen
Journal:  Open Life Sci       Date:  2020-07-27       Impact factor: 0.938

7.  Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma.

Authors:  Weijie Min; Dongwei Dai; Jiaqi Wang; Dandan Zhang; Yuhui Zhang; Guosheng Han; Lei Zhang; Chao Chen; Xiulong Li; Yanan Li; Zhijian Yue
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

Review 8.  The miR-200 family: multiple effects on gliomas.

Authors:  Lilei Peng; Jie Fu; Yang Ming
Journal:  Cancer Manag Res       Date:  2018-07-13       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.